Logo image of SFE

SAFEGUARD SCIENTIFICS INC (SFE) Stock Fundamental Analysis

NASDAQ:SFE - Nasdaq - US7864493066 - Common Stock - Currency: USD

0.455  -0.2 (-30.21%)

After market: 0.56 +0.11 (+23.08%)

Fundamental Rating

2

SFE gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 237 industry peers in the Capital Markets industry. SFE has a great financial health rating, but its profitability evaluates not so good. SFE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year SFE has reported negative net income.
SFE had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: SFE reported negative net income in multiple years.
In the past 5 years SFE always reported negative operating cash flow.
SFE Yearly Net Income VS EBIT VS OCF VS FCFSFE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 50M -50M

1.2 Ratios

SFE's Return On Assets of -32.10% is on the low side compared to the rest of the industry. SFE is outperformed by 98.53% of its industry peers.
SFE has a worse Return On Equity (-34.78%) than 95.59% of its industry peers.
Industry RankSector Rank
ROA -32.1%
ROE -34.78%
ROIC N/A
ROA(3y)-14.12%
ROA(5y)-0.46%
ROE(3y)-15.87%
ROE(5y)-3.44%
ROIC(3y)N/A
ROIC(5y)N/A
SFE Yearly ROA, ROE, ROICSFE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 50 -50 -100

1.3 Margins

SFE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SFE Yearly Profit, Operating, Gross MarginsSFE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022

More info and screens

7

2. Health

2.1 Basic Checks

SFE has less shares outstanding than it did 1 year ago.
SFE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SFE Yearly Shares OutstandingSFE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M
SFE Yearly Total Debt VS Total AssetsSFE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M 250M

2.2 Solvency

SFE has an Altman-Z score of -29.56. This is a bad value and indicates that SFE is not financially healthy and even has some risk of bankruptcy.
SFE has a Altman-Z score of -29.56. This is amonst the worse of the industry: SFE underperforms 95.10% of its industry peers.
There is no outstanding debt for SFE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -29.56
ROIC/WACCN/A
WACCN/A
SFE Yearly LT Debt VS Equity VS FCFSFE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 50M 100M 150M

2.3 Liquidity

SFE has a Current Ratio of 10.19. This indicates that SFE is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 10.19, SFE belongs to the top of the industry, outperforming 94.61% of the companies in the same industry.
A Quick Ratio of 10.19 indicates that SFE has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 10.19, SFE belongs to the top of the industry, outperforming 94.61% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 10.19
Quick Ratio 10.19
SFE Yearly Current Assets VS Current LiabilitesSFE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M

More info and screens

0

3. Growth

3.1 Past

SFE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.19%, which is quite impressive.
EPS 1Y (TTM)40.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%131.58%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SFE Yearly EPS VS EstimatesSFE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 0 2 -2 -4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SFE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SFE Price Earnings VS Forward Price EarningsSFE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SFE Per share dataSFE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SFE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SAFEGUARD SCIENTIFICS INC

NASDAQ:SFE (2/9/2024, 8:07:22 PM)

After market: 0.56 +0.11 (+23.08%)

0.455

-0.2 (-30.21%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-02 2023-11-02/amc
Earnings (Next)03-07 2024-03-07/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners14.36%
Ins Owner Change0%
Market Cap7.54M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.25
P/tB 0.25
EV/EBITDA N/A
EPS(TTM)-0.64
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.19
OCFYN/A
SpS0
BVpS1.8
TBVpS1.8
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -32.1%
ROE -34.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-14.12%
ROA(5y)-0.46%
ROE(3y)-15.87%
ROE(5y)-3.44%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.19
Quick Ratio 10.19
Altman-Z -29.56
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%131.58%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y52.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y52.31%
OCF growth 3YN/A
OCF growth 5YN/A